iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Trading Up 0.5% – Time to Buy?

Shares of iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) were up 0.5% on Wednesday . The company traded as high as $23.81 and last traded at $23.81. Approximately 336 shares were traded during mid-day trading, a decline of 44% from the average daily volume of 601 shares. The stock had previously closed at $23.68.

iShares Neuroscience and Healthcare ETF Stock Performance

The company has a 50-day moving average price of $25.15 and a 200-day moving average price of $25.75. The firm has a market capitalization of $3.55 million, a P/E ratio of 28.31 and a beta of 0.72.

Institutional Trading of iShares Neuroscience and Healthcare ETF

A hedge fund recently bought a new stake in iShares Neuroscience and Healthcare ETF stock. Jane Street Group LLC bought a new stake in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned approximately 6.77% of iShares Neuroscience and Healthcare ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.